A Proof of Principle Study of Pembrolizumab With SBRT in TKI mRCC Patients

NCT02599779 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

4

Enrollment

OTHER

Sponsor class

Conditions

Stage IV Renal Cell Cancer AJCC V7

Interventions

DRUG: Pembrolizumab
RADIATION: Stereotactic Body Radiation Therapy

Sponsor

Sunnybrook Health Sciences Centre

Collaborators

[object Object]
[object Object]